FDA Adverse Event Injury Summary report: N

MENSTRUAL PAD (UNSPECIFIED)

MDR report key: 22995032 · Received September 8, 2025

Report

Report Number
3014829931-2025-00005
Event Type
Injury
Date Received
September 8, 2025
Report Date
September 8, 2025
Manufacturer
SHANGHAI SHUXIAO INDUSTRY CO.,LTD
Product Code
HHL
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

FOR THIS INVESTIGATION, NO SPECIFIC MENSTRUAL PAD PRODUCT NOR LOT CODE WAS REPORTED BY THE CONSUMER. THEREFORE, A DOCUMENTATION REVIEW WAS PERFORMED ON THE HONEY POT COMPANY'S TOP-SELLING MENSTRUAL PAD PRODUCT. THIS REVIEW WAS PERFORMED ON THE HONEY POT COMPANY'S ORGANIC TOP SHEET HERBAL REGULAR PADS. QC INSPECTION RECORDS OF (B)(4) LOTS MANUFACTURED IN 2025 OF THE ORGANIC TOP SHEET HERBAL REGULAR PADS WERE REVIEWED AND IT WAS CONFIRMED THAT ALL IN-PROCESS CHECKS WERE PERFORMED, AND THE RESULTS OF THOSE CHECKS WERE IN COMPLIANCE WITH THE SPECIFICATION.

Description of Event or Problem · 0

ON 18-MAY-2025, A SPONTANEOUS REPORT WAS RECEIVED VIA EMAIL REGARDING A FEMALE CONSUMER OF UNSPECIFIED AGE WHO USED AN UNSPECIFIED THE HONEY POT PAD. AN ADDITIONAL EMAIL ON BEHALF OF THIS CONSUMER WAS RECEIVED ON (B)(6) 2025. BOTH CONTACTS WILL BE TREATED AS AN INITIAL REPORT. ON AN UNSPECIFIED DATE, THE CONSUMER BEGAN USING THE HONEY POT UNSPECIFIED PAD AT AN UNKNOWN FREQUENCY. NO LOT NUMBER OR EXPIRATION DATE WAS PROVIDED. ON AN UNSPECIFIED DATE AFTER USING THE PRODUCT, SHE DEVELOPED CHEMICAL BURNS CAUSING VAGINAL EROSION AND AN INVASIVE YEAST INFECTION REQUIRING HOSPITALIZATION. AS OF (B)(6) 2025, SHE REMAINED HOSPITALIZED. NO FURTHER CLINICAL DETAILS WERE PROVIDED. AT THE TIME OF REPORTING, NO FURTHER INFORMATION WAS AVAILABLE. ADDITIONAL ATTEMPTS TO REACH THE CONSUMER VIA EMAIL ON (B)(6) 2025 TO ASCERTAIN ADDITONAL CASE DETAILS WERE UNSUCCESSFUL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2441123 MENSTRUAL PAD (UNSPECIFIED) PAD, MENSTRUAL HHL SHANGHAI SHUXIAO INDUSTRY CO.,LTD

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention| H